Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000950170-25-096948)

Filing Details

Accession Number:: 0000950170-25-096948
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-07-18 16:30:06
Reporting Period:: 2025-07-16

Filing Date:: 2025-07-18
Accepted Time:: 2025-07-18 16:30:06
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1395937	Syndax Pharmaceuticals Inc	SNDX	Pharmaceutical Preparations (2834)	320162505

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1495411	A. Keith Goldan	730 Third Avenue Floor 9 New York NY 10017	Chief Financial Officer	No	No	No	No

Transaction Summary

Sold:	1,296 shares	Avg. Price: $9.29	Total Value: $12,033.36
Number of Shares After Transactions:	92,450 shares

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2025-07-16	1,296	$9.29	92,450	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units.